Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investors Events
  • Pre market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
Blackstone Inc., Park Avenue, New York City.
January 30, 2026 1:37 AM 2 min read

Blackstone Says Deal Cycle Has Hit 'Escape Velocity' As IPO, M&A Activity 'Feels Like 2013' Again

by Vishaal Sanjay
Follow

ArticleFeaturedTickersList12345!!!

Private equity giant Blackstone Inc. (NYSE:BX) said that the long-awaited recovery in global dealmaking is now firmly underway, with executives pointing to accelerating IPO and M&A activity following a multi-year freeze.

Deal Cycle Has Hit ‘Escape Velocity’

During the company's fourth-quarter earnings call on Thursday, Chief Operating Officer Jonathan Gray said, “This is an exciting time for Blackstone, with three powerful dynamics coming together,” pointing to the reopening of the deal cycle, rising investment tied to artificial intelligence and growing adoption of private markets across investor channels.

Gray said the firm is now seeing the resurgence it had been anticipating, following several years of subdued transaction activity. “IPO and M&A activity are accelerating, deal sizes are increasing, and sponsor activity is picking up,” he said.

According to Blackstone, global IPO issuance surged 40% year-over-year during the fourth quarter, including a two-and-a-half-fold increase in the U.S. alone.

The offering was “extremely well received,” Gray said, noting that Medline shares traded up more than 40% on their first day.

Gray likened the current environment to the post-financial-crisis reopening of capital markets. “It feels like 2013–2014, where you had that four, five-year hibernation period, the markets reopened, and we took a bunch of companies public,” he said. “And that is the way it feels today.”

He added that the return of exits is already improving limited partner liquidity. “As they get capital back, as they get gains back, it makes it easier for them to allocate more capital to us,” he said. “It does get that flywheel going again.”

Stock Slides Following Q4 Results

Blackstone released its fourth-quarter results on Thursday, reporting $3.94 billion in revenue, down 5% year-over-year, compared to $4.14 billion, and ahead of consensus estimates of $3.70 billion.

Distributable earnings during the quarter stood at $2.2 billion, or $1.75 per share, up from $2.1 billion, or $1.69 a year ago, and ahead of analyst consensus estimates at $1.53 per share.

Shares of Blackstone dropped 2.62% on Thursday, closing at $142.94 and are down 0.55% overnight. The stock has a poor Momentum score in Benzinga’s Edge Stock Rankings, but scores well on Quality. It has a weak price trend in the short, medium and long terms.

Photo courtesy: Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


Posted In:
EarningsEquitiesM&ANewsPrivate MarketsFinancingIPOsMarkets
BX Logo
BXBlackstone Inc
$142.60-0.24%
Overview
MDLN Logo
MDLNMedline Inc
$43.750.05%

The firm played a central role in this resurgence, having led the $7.2 billion initial public offering of Medline Inc. (NASDAQ:MDLN), which Gray described as “the largest IPO since 2021, and the largest sponsor-backed IPO in history.”

BX Logo
BXBlackstone Inc
$142.60-0.24%
Overview
MDLN Logo
MDLNMedline Inc
$43.750.05%
Comments
Loading...